Exotropia

disease
On this page

Also known as divergent concomitant strabismusdivergent strabismus

Summary

Exotropia (MONDO:0001286) is a disease and 44 clinical trials. Top therapeutic interventions include botulinum toxin type a and sodium chloride. A subtype of strabismus — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • ClinVar variants: 3
  • Clinical trials: 44

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical nameexotropia
Mondo IDMONDO:0001286
MeSHD005099
DOIDDOID:1143
ICD-10-CMH50.1
ICD-112116859618
NCITC34601
SNOMED CT399252000
UMLSC0015310
MedGen4613
Is cancer (heuristic)no

Also known as: divergent concomitant strabismus · divergent strabismus

Data availability: 3 ClinVar variants.

Disease family

This is a subtype of strabismus. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › nervous system disordercranial nerve neuropathyocular motility diseasestrabismusexotropia

Related subtypes (10): paralytic strabismus, conjugate gaze palsy, intermittent squint, internuclear ophthalmoplegia, mechanical strabismus, hypertropia, cyclotropia, esotropia, hypotropia, monofixation syndrome

Subtypes (2): alternating exotropia, monocular exotropia

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

ClinVar germline variants

3 retrieved; paginated sample, class counts are floors:

2 uncertain significance, 1 pathogenic

ClinVarVariant (HGVS)GeneClassificationReview
26788346;X;inv(X)(p11.4q24)dnPathogeniccriteria provided, single submitter
26782346;XY;t(6;11)(q23;q21)or(q25;q21)dnUncertain significancecriteria provided, single submitter
26794246;XY;t(1;14)(q42;q13)Uncertain significancecriteria provided, single submitter

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 44.

Phase distribution (across all retrieved trials)

PhaseTrials
Not specified40
PHASE2/PHASE32
PHASE41
PHASE31

Top trials by phase / activity

NCTPhaseStatusTitle
NCT01460355PHASE4COMPLETEDComparison of Two Treatments for Strabismus Correction: Botulinum Toxin A Associated to Surgery and Surgery Alone
NCT01616108PHASE2/PHASE3UNKNOWNBupivacaine Injection of Eye Muscles to Treat Strabismus
NCT03768362PHASE2/PHASE3UNKNOWNComparison of Medial Rectus Resection and Plication in Exotropic Patients
NCT05462821PHASE3COMPLETEDFull-Time Occlusion Therapy for Intermittent Exotropia in Children
NCT04199871Not specifiedACTIVE_NOT_RECRUITINGImproving Control of Alignment in Intermittent Exotropia
NCT04487249Not specifiedRECRUITINGTrial of Vision Therapy for Intermittent Exotropia
NCT05379855Not specifiedRECRUITINGA-eyedrops on Ocular Alignment and Binocular Vision
NCT06594666Not specifiedNOT_YET_RECRUITINGVisual Training for Improving Intermittent Exotropia Visual Function
NCT06650735Not specifiedACTIVE_NOT_RECRUITINGBilateral Lateral Rectus Recession Versus Bilateral Primary Medial Rectus Resection in Intermittent Exotropia
NCT06762067Not specifiedNOT_YET_RECRUITINGExercise Training on a Mirror for Intermittent Exotropia Control Post Strabismus Surgery
NCT07272005Not specifiedRECRUITINGImproving Control of Intermittent Exotropia
NCT07350330Not specifiedRECRUITINGComparative Study of Muscle Transplantation Versus Y Splitting Recession Technique in Treatment of Large Angle Exotropia
NCT07446621Not specifiedNOT_YET_RECRUITINGRisk Factors And Surgical Outcomes Of Strabismus Reoperation
NCT01032330Not specifiedCOMPLETEDObservation Versus Occlusion Therapy for Intermittent Exotropia
NCT01032603Not specifiedCOMPLETEDBilateral Lateral Rectus Recession Versus Unilateral Recess-Resect for Intermittent Exotropia
NCT01267500Not specifiedTERMINATEDStudy of Non-surgical Treatment Versus Observation in Asian Children With Intermittent Exotropia
NCT02131792Not specifiedCOMPLETEDEarly Results of Slanted Recession of the Lateral Rectus Muscle for Intermittent Exotropia With Convergence Weakness
NCT02223650Not specifiedCOMPLETEDA Pilot Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
NCT02383381Not specifiedCOMPLETEDLateral Rectus Muscle and Anterior Segment Optical Coherence Tomography (AS-OCT)
NCT02450162Not specifiedUNKNOWNLateral Rectus Muscle and Anterior Segment Optical Coherence Tomography (AS-OCT) in Two Recession Surgeries
NCT02466659Not specifiedTERMINATEDControlled Intermittent Alternate Occlusion (CIAO) Therapy for Intermittent Exotropia
NCT02570555Not specifiedCOMPLETEDStrabismus Surgery and Driving Ability
NCT02699580Not specifiedCOMPLETEDProtective Effect of Biodegradable Collagen Implant (Ologen) in Scleral Thinning After Strabismus Surgery
NCT02807350Not specifiedCOMPLETEDTrial of Overminus Spectacle Therapy for Intermittent Exotropia
NCT02902887Not specifiedUNKNOWNMonitored Controlled Intermittent Alternate Occlusion (CIAO) Therapy for Intermittent Exotropia
NCT03119311Not specifiedCOMPLETEDA Novel Diagnostic Method for Exotropia Using Video-oculography
NCT03321838Not specifiedUNKNOWNOffice Based Vergence and Accommodative Therapy and Intermittent Exotropia
NCT03641040Not specifiedUNKNOWNThe Analysis of Ocular Deviations Between Dominant and Non-dominant Eye Using Video-oculography (VOG) in Intermittent Exotropia
NCT03661476Not specifiedCOMPLETEDThe Effect of Oculo-Motor Exercises in Intermittent Exotropia
NCT03700632Not specifiedUNKNOWNPart-time Patch Therapy for Treatment of Intermittent Exotropia
NCT03952702Not specifiedUNKNOWNOverminus Lens Therapy in Intermittent
NCT04263103Not specifiedUNKNOWNA Training Software (SJ-RS-WL2015) Rehabilitating Intermittent Exotropia Binocular Functions
NCT04307160Not specifiedUNKNOWNRelationship of Age at Surgery to Surgical Outcome After Surgery for Intermittent Exotropia
NCT04744779Not specifiedUNKNOWNOffice Based Vergence/Accommodative Therapy for the Treatment of Intermittent Exotropia
NCT04961021Not specifiedCOMPLETEDManagement of Consecutive Exotropia
NCT05089422Not specifiedUNKNOWNStudy of Clinical Types and Surgical Out Come of Pediatric Exotropia
NCT05234957Not specifiedCOMPLETEDSymmetric vs Asymmetric BLR Recession in Management of Basic IXT With Ocular Dominance
NCT05242510Not specifiedTERMINATEDEvaluation of Exotropia After Patching the Eye or After Prism Adaptation
NCT05615519Not specifiedUNKNOWNValidation of a Smartphone-based Intelligent Diagnosis and Measurement for Strabismus
NCT05643456Not specifiedCOMPLETEDSurgery for Large Angle Exotropia Two Muscles Versus Three Muscles

Drugs tested across these trials (top 30)

MoleculeMax phaseTrials referencing
BOTULINUM TOXIN TYPE A41
SODIUM CHLORIDE41